1. Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy Istituto Nazionale Tumori IRCCS Fondazione Pascale Naples Italy
2. FSBI “N.N. Blokhin National Medical Research Center of Oncology” of the Ministry of Health of the Russian Federation Moscow Russian Federation
3. Division of Medical Oncology Candiolo Cancer Institute, FPO—IRCCS, Candiolo Turin Italy
4. Department of Soft Tissue/Bone Sarcoma and Melanoma Maria Sklodowska‐Curie National Research Institute of Oncology Warsaw Poland
5. Sackler Faculty of Medicine Tel Aviv University Tel Aviv Israel
6. Istituto Oncologico Veneto ‐ IOV IRCCS Padova Italy
7. Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors European Institute of Oncology (IEO), IRCCS Milan Italy
8. Dermatology Department University Hospital of Tours Tours France
9. Dermatology Clinic CARADERM and University of Lille, INSERM U1189, Lille Hospital–Claude Huriez Hospital Lille Cedex France
10. Department of Dermatology and Venereology University Medical Center Hamburg‐Eppendorf (UKE) Hamburg Germany
11. Department of Dermatology Hôpital Cochin, AP‐HP Paris France
12. Institute of Immunology and Immunotherapy University of Birmingham Birmingham UK
13. Department of General Medical Oncology University Hospitals Leuven, KU Leuven Leuven Belgium
14. Department of Medical Oncology Hospital Clínic Barcelona Spain
15. The healthcare business of Merck KGaA Darmstadt Germany
16. Merck spol. s r.o., Bratislava, Slovakia, an affiliate of Merck KGaA Darmstadt Germany
17. Pfizer Inc. Porto Salvo Portugal
18. Division of Cancer Sciences University of Manchester and the Christie NHS Foundation Trust Manchester UK